Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome.

Ajani, J A; Mansfield, P F; Crane, C H; Wu, T T; Lunagomez, S; Lynch, P M; Janjan, N; Feig, B; Faust, J; Yao, J C; Nivers, R; Morris, J; Pisters, P W

Ajani, J A; Mansfield, P F; Crane, C H; Wu, T T; Lunagomez, S; Lynch, P M; Janjan, N; Feig, B; Faust, J; Yao, J C; Nivers, R; Morris, J; Pisters, P W.

Affiliation

Ajani JA; Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-4009, USA. jajani@mdanderson.org

J Clin Oncol ; 23(6): 1237-44, 2005 Feb 20.

Article in En | MEDLINE | ID: mdl-15718321

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Adenocarcinoma / Chemotherapy, Adjuvant / Paclitaxel / Radiotherapy, Adjuvant Type of study: Prognostic_studies Limits: Female / Humans / Male Language: En Journal: J Clin Oncol Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links